Midi Health review
Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform.
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
Midi Health earns a Match Score of 50/100 (grade C) and sits #445 of 497 on our board under the balanced default weighting.
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Oral option
- Injectable only
- Verification
- Not independently listed
Best for: People who want menopause-focused care with GLP-1 as a metabolic adjunct.
MatchScript's take: Our #445 pick of 497 — confirmed nationwide access, scored on the same six factors as everyone else.
The factor breakdown
Midi Health on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Its lowest tier isn't clearly disclosed puts Budget Fit at a below-par 48 — above the budget tiers.
Confirmed all-50-state access means it can usually prescribe within days, for a below-par 70 on Speed to Start.
Midi Health sticks to compounded injectables, for a below-par 40 on Formulary Match.
Support lands at a below-par 71 — lighter, meds-first support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
Disclosure here is thinner than the top of the board give a below-par 20 on Transparency.
Pricing in context
How Midi Health's monthly price sits against the category median and the cheapest provider we track.
What we like
- Available in all 50 states
- Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
- Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
- Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)
The caveats
- Does not accept Medicare, Medicaid, or Medi-Cal
- GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
- Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
Who it's for — and who should skip it
Choose Midi Health if people who want menopause-focused care with GLP-1 as a metabolic adjunct.
Skip it if that doesn't sound like you. A closer fit may be Actin (Match Score 50) — or take the quiz to see where Midi Health lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Midi Health against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Midi Healththis provider | CoreAge Rxour #1 | Actinclosest scorer |
|---|---|---|---|
| Sema price | Not disclosed | $149/mo | $169/mo (compounded) |
| Coverage | All 50 states | All 50 states | Coverage not published |
| Formulary | Injectable | Injectable | Injectable |
| Match Score | 50 · C | 91 · A− | 50 · C |
Midi Health, answered
Is Midi Health legit?
Midi Health is a real, operating GLP-1 telehealth program, but we don't find it on the LegitScript registry, so it carries less third-party verification than the certified providers on our board. It dispenses compounded medication, which isn't FDA-approved. Vet the prescriber and pharmacy before you commit.
How much does Midi Health cost?
Midi Health doesn't publish a clear compounded-semaglutide price up front. You'll typically see full pricing after the intake questionnaire. Get the all-in monthly number in writing before you pay.
Does Midi Health ship to my state?
Yes — Midi Health reports availability in all 50 states, so most people can start within days.
Midi Health vs CoreAge Rx — which is better?
Both are on our board. Midi Health scores 50/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. Midi Health can still win for you if its strengths match your priorities — best for: People who want menopause-focused care with GLP-1 as a metabolic adjunct. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified July 2026 from Midi Health's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Midi Health's site. Not medical advice; see our disclosure.
Midi Health earns a Match Score of 50/100 (grade C) and sits #445 of 497 on our board under the balanced default weighting. Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. Best for: People who want menopause-focused care with GLP-1 as a metabolic adjunct. If it isn't the right fit, Actin is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Midi Health on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| PrescribedRX#446 | 50 | $189/mo (compounded) | $276/mo (compounded) | Coverage not published | Alternatives | Visit |
| RxION Health#447 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Vida Health#448 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Zealthy#449 | 50 | $286/mo (starting dose, plus a separate fee, compounded) | $351/mo (starting dose, plus a separate fee, compounded) | 34 states | Alternatives | Visit |
| Aspire Health#450 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Elevate Health#451 | 49 | $299/mo (compounded) | $399/mo (compounded) | Coverage not published | Alternatives | Visit |
| Enara Health#452 | 49 | Not disclosed | Not disclosed | 6 states | Alternatives | Visit |
| Evolve Telemed#453 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Garcia Weight Loss, Aesthetics & Hormone Therapy#454 | 49 | $400/mo (starting dose, compounded) | Not disclosed | 1 states | Alternatives | Visit |
| Genesis Lifestyle Medicine#455 | 49 | Not disclosed | Not disclosed | 8 states | Alternatives | Visit |
| MDExam#456 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| MultiMedRx#457 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Omzo#458 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| RegenCen#459 | 49 | Not disclosed | Not disclosed | 2 states | Alternatives | Visit |
| Royal Medical Center#460 | 49 | Not disclosed | $450/mo (2.5 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| Tablet Health#461 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Trimrose#462 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| WellMedRx#463 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Wellspring Longevity Clinic#464 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| ZipHealth#465 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Beluga Health#466 | 48 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| DadVantage Men's Health#467 | 48 | Not disclosed | Not disclosed | 1 states | Alternatives | Visit |
| EllieMD#468 | 48 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Nucific#469 | 48 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |